Previous close | 7.79 |
Open | 6.20 |
Bid | 3.40 |
Ask | 9.60 |
Strike | 380.00 |
Expiry date | 2025-01-17 |
Day's range | 6.20 - 6.50 |
Contract range | N/A |
Volume | |
Open interest | 146 |
Vertex Pharmaceuticals Inc (VRTX) reports robust revenue growth and raises guidance, while addressing acquisition-related losses and strategic hurdles.
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
We recently published a list of Renaissance Technologies Portfolio: 10 Best Stocks To Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other best stocks to buy which are part of the Renaissance Technologies portfolio. Renaissance Technologies is an American hedge fund that specializes […]